Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Condition:   Prostate Cancer Interventions:   Drug: DFMO;   Drug: testosterone cypionate;   Drug: Luteinizing hormone-releasing hormone (LHRH) analogue;   Drug: Enzalutamide Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Panbela Therapeutics;   Prostate Cancer Foundation;   United States Department of Defense Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials